Search results for " mRNA"

Article Accelerating the Development of mRNA Therapeutics
Manufacturing and processing challenges surrounding mRNA can be overcome in order to realize the true potential of a technology 30 years in the making. READ FULL ARTICLE >>

Article New to mRNA manufacturing? Here's what you need to know
Click above for an in-depth guide on mRNA manufacturing.

Article mRNA Vaccines: Current Trends and Perspectives
There are still challenges to overcome to fully realize the potential of this technology, but the COVID-19 pandemic publicly demonstrated the promise of mRNA therapies. The future looks bright for thi…

Article Increasing mRNA Capabilities and Capacity for Growing Market Needs
Click here to read more >> The success of the mRNA vaccine market is fueling high demand for mRNA, resulting in a critical need to address the manufacturing bottlenecks.

Article Discussing the Origins of the mRNA Therapeutics Field
Andy Geall, co-founder and chief development officer at Replicate Bioscience, discusses the historical context and buildup of the mRNA therapeutics field. Watch video

Article Process Development challenges for mRNA vaccines and beyond
Key insights from industry experts on the future of therapeutic mRNA manufacturing. READ MORE >>

Article mRNA vaccines: current trends and perspectives
The promise and challenges of mRNA vaccine development. READ MORE >> 

Article mRNA Global Alliance Tests the Waters at BIO
World leaders have set ambitious goals to respond more swiftly to the next pandemic, including the US goal to design, test, and review a new vaccine just 100 days after a pandemic declaration.…

Article Increasing mRNA capabilities and capacity for growing market needs
The rapid development of innovative vaccines allowed for the pharmaceutical industry to deliver its first tools in the fight against the COVID-19 pandemic. READ FULL ARTICLE >>

Article Analysis of mRNA Therapeutics and Vaccines
Analytical approaches must keep pace to ensure the identity, safety, and efficacy of evolving mRNA candidates. Read more here >>>

Previous PageNext Page